Neonatal bilateral lidocaine administration into the ventral hippocampus caused postpubertal behavioral changes: An animal model of neurodevelopmental psychopathological disorders

Neuropsychiatric Disease and Treatment

Volumn 5, Issue 1, 2009, Pages 15-22

  Blas Valdivia, Vanessa ^a   Cano Europa, Edgar ^a   Hernández García, Adelaida ^a   Ortiz Butrón, Rocio ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Animal model; Behavior; Hippocampus; Lidocaine; Neonatal lesion; Psychopathological disorders

Indexed keywords

LIDOCAINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; HIPPOCAMPUS; IMMOBILIZATION; LATENT PERIOD; LOCOMOTION; MALE; MENTAL DISEASE; NEWBORN; NONHUMAN; NUCLEOLUS; OPEN FIELD TEST; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STIMULUS; TAIL FLICK TEST;

EID: 70449699770     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. De Jong RH. Local Anesthetics. St Louis, MO: Mosby; 1994. p. 250-303.
2. Steen PA, Michenfelder JD. Neurotoxicity of anesthetics. Anesthesiology. 1979;50:437-453.
3. Post RM, Kennedy C, Shinohara M, et al. Metabolic and behavioral consequences of lidocaine-kindled seizures. Brain Res. 1984;324:295-303. (Pubitemid 15195963)
4. Blas-Valdivia V, Cano-Europa E, Hernandez-Garcia A, Ortiz-Butron R. Hippocampus and amygdala neurotoxicity produced by systemic lidocaine in adult rats. Life Sci. 2007;81:691-694. (Pubitemid 47271907)
5. Courchesne E. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol. 1997;7:269-278. (Pubitemid 27219864)
6. Marsden CA. Dopamine: the rewarding years. Br J Pharmacol. 2006;147(Suppl 1):S136-S144.
7. Bogerts B, Lieberman JA, Ashtari M, et al. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry. 1993;33:236-246. (Pubitemid 23091498)
8. Harrison PJ. The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain. 1999;122:593-624.
9. Schmajuk NA. Hippocampal dysfunction in schizophrenia. Hippocampus. 2001;11:599-613.
10. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals schizophrenia such a reality test. Neuropsychopharmacology. 2000;23:223-239.
11. Stefan M, Travis M, Murray RM. An Atlas of Schizophrenia. London: Informa HealthCare; 2002.
12. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry. 2006;39(Suppl 1):S10-S14.
13. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl). 1995;122:35-43.
14. Grecksch G, Bernstein HG, Becker A, Hollt V, Bogerts B. Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology. 1999;20:525-532. (Pubitemid 29189257)
15. Becker A, Grecksch G, Bernstein HG, Hollt V, Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berl). 1999;144:333-338. (Pubitemid 29307257)
16. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology. 2002;27:47-54. (Pubitemid 34626742)
17. Sams-Dodd F, Lipska BK, Weinberger DR. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl). 1997;132:303-310. (Pubitemid 27351432)
18. Flores G, Silva-Gomez AB, Barbeau D, Srivastava LK, Zamudio S, De La Cruz Lopez F. Effect of excitotoxic lesions of the neonatal ventral hippocampus on the immobility response in rats. Life Sci. 2005;76:2339-2348. (Pubitemid 40313421)
19. Al Amin HA, Atweh SF, Jabbur SJ, Saade NE. Effects of ventral hippocampal lesion on thermal and mechanical nociception in neonates and adult rats. Eur J Neurosci. 2004;20:3027-3034.
20. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 1993;9:67-75.
21. Rex A, Voigt JP, Gustedt C, Beckett S, Fink H. Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test. Psychopharmacology (Berl). 2004;177:23-34. (Pubitemid 40109911)
22. Zamudio S, Fregoso T, Miranda A, De La Cruz F, Flores G. Strain differences of dopamine receptor levels and dopamine related behaviors in rats. Brain Res Bull. 2005;65:339-347. (Pubitemid 41057804)
23. Walsh RN, Cummins RA. The open-field test: a critical review. Psychol Bull. 1976;83:482-504.
24. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1999.
25. Post MR, Kopanda RT, Lee A. Progressive behavioral changes during chronic lidocaine administration: relationship to kindling. Life Sci. 1975;17:943-950.
26. Maaswinkel H, Gispen WH, Spruijt BM. Executive function of the hippocampus in social behavior in the rat. Behav Neurosci. 1997;111:777-784. (Pubitemid 27335388)
27. Daenen EW, Wolterink G, Gerrits MA, Van Ree JM. The effects of neonatal lesions in the amygdala or ventral hippocampus on social behaviour later in life. Behav Brain Res. 2002;136:571-582. (Pubitemid 35333272)
28. Wan RQ, Corbett R. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology. 1997;16:259-268. (Pubitemid 27147924)
29. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol. 1996;7:3-23. (Pubitemid 26051782)
30. Marinelli M, White FJ. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci. 2000;20:8876-8885.
31. Meyer ME, Cottrell GA, Van Hartesveldt C. Intracerebral haloperidol potentiates the dorsal immobility response in the rat. Pharmacol Biochem Behav. 1993;44:157-160. (Pubitemid 23025303)
32. Daenen EW, Wolterink G, Gerrits MA, Van Ree JM. Amygdala or ventral hippocampal lesions at two early stages of life differentially affect open field behaviour later in life; an animal model of neurodevelopmental psychopathological disorders. Behav Brain Res. 2002;131:67-78. (Pubitemid 34143157)
33. Carter CJ, Pycock CJ. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 1980;192:163-176.
34. Del Arco A, Mora F. Prefrontal cortex-nucleus accumbens interaction: In vivo modulation by dopamine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav. 2008;90:226-235.
35. Hagelberg N, Jaaskelainen SK, Martikainen IK, et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol. 2004;500:187-192. (Pubitemid 39304007)
36. Chudler EH. Response properties of neurons in the caudate-putamen and globus pallidus to noxious and non-noxious thermal stimulation in anesthetized rats. Brain Res. 1998;812:283-288.
37. Lautenbacher S, Krieg JC. Pain perception in psychiatric disorders: a review of the literature. J Psychiatr Res. 1994;28:109-122. (Pubitemid 24157366)
38. López-Galindo GE, Cano-Europa E, Ortiz-Butron R. Ketamine prevents lidocaine-caused neurotoxicity in the CA3 hippocampal and basolateral amygdala regions of the brain of adult rats. J Anesthesia. 2008; In Press.
39. Raley-Susman KM, Kass IS, Cottrell JE, Newman RB, Chambers G, Wang J. Sodium influx blockade and hypoxic damage to CA1 pyramidal neurons in rat hippocampal slices. J Neurophysiol. 2001;86:2715-2726. (Pubitemid 33139042)
40. Waraczynski M. Lidocaine inactivation demonstrates a stronger role for central versus medial extended amygdala in medial forebrain bundle self-stimulation. Brain Res. 2003;962:180-198. (Pubitemid 36126335)